PediaLink & EQIPP Courses /

Adolescent Substance Use Screening and Intervention

Name: Adolescent Substance Use Screening and Intervention
Brand: American Academy of Pediatrics
SKU: 479178ED-FCA7-410A-A5D0-D3899B46433D
Availability: InStock

MOC

Available: 08/28/2026-08/27/2029

Format

Price: $0.00

Member Price: $0.00

Description and Learning Objectives

Description

Adolescent and young adult substance use is a critical pediatric health issue because it often begins during a developmental period marked by rapid brain, social, and emotional growth. Substance use can affect safety, mental health, school functioning, family relationships, and long-term well-being, and it may increase the risk for injury, overdose, infectious disease exposure, and progression to substance use disorder.

This course series prepares pediatric trainees and clinicians to respond to substance use with evidence-informed, developmentally appropriate, and nonjudgmental care.

Upon completion of this course, you will be able to

Describe current and evolving epidemiologic patterns of adolescent substance use, including emerging substances, changing modes of use, and associated risk and protective factors.

Summarize key recommendations from existing and emerging clinical practice guidelines for screening, brief intervention, and treatment.

Demonstrate developmentally appropriate, patient-centered counseling and prevention strategies, using motivational interviewing techniques with approaches that recognize substance use within the broader context of a young person’s life and experiences.

Use evidence-based clinical pathways to identify and manage adolescent substance use, including assessing co-occurring mental health conditions (eg, ADHD, anxiety, depression), evaluating the need for medications for substance use disorders, and coordinating care with behavioral health and substance use services.

Implement evidence-based treatment strategies for adolescents presenting with co-use or polysubstance use, including tailoring interventions based on clinical complexity, managing withdrawal when appropriate, and promoting safety and continuity of care.

Course Details

Start Date: August 28, 2026
Online Access Expires: August 27, 2029
Credit Expires: August 27, 2029
Course ID: 62767

Faculty

Sarah Bagley, MD
Ashely Ebersole, MD, MS, FAAP
Allison Heinly, MD, FAAP
Andrew Terranella, MD, MPH, FAAP

Registration Fees

AAP Member Registration Fee: $0

Non-Member Registration Fee: $0

Credit Information

AMA PRA Category 1 Credit™
Enduring Materials

2.50
MOC
MOC Part 2

2.50
AAPA
AAPA Credit Hours

2.50

Credit Statements

Physician - Adolescent Substance Use Screening and Intervention

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 2.50 points of MOC Part 2 credit by the American Board of Pediatrics through the AAP MOC Portfolio Program. All approved activities must be completed by the MOC Credit Approval End Date. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician’s ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact [email protected].

Allied Health Professional - Adolescent Substance Use Screening and Intervention

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

PAs may claim a maximum of 2.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

This program is accredited for 0.00 NAPNAP CE contact hours of which 0.00 contain pharmacology (Rx) content, (0.00 related to psychopharmacology) (0.00 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines. The AAP is designated as Agency #A17. Upon completion of the program, each participant desiring NAPNAP contact hours must send a completed certificate of attendance to [email protected]. Payment of $15 for NAPNAP members and nonmembers is required via credit card for all NAPNAP contact hour requests. Keep this certificate for your records for six (6) years. Requests for duplicate certificates should be made to the AAP.

Technical Requirements

Recommended Browsers: